BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jeng KS, Huang CC, Lin CC, Lin CK, Teng CJ, Chen KH. Liver Transplantation After Downstagings of Ruptured Advanced Hepatocellular Carcinoma in Cirrhotic Liver: Is It Advisable? A Case Report. Transplant Proc 2019;51:1468-71. [PMID: 31056250 DOI: 10.1016/j.transproceed.2019.01.125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Xu L, Chen L, Zhang W. Neoadjuvant treatment strategies for hepatocellular carcinoma. World J Gastrointest Surg 2021; 13(12): 1550-1566 [DOI: 10.4240/wjgs.v13.i12.1550] [Reference Citation Analysis]
2 Lee HY, Hong SK, Hong SY, Suh S, Han ES, Lee JM, Choi Y, Yi NJ, Lee KW, Suh KS. Outcomes of Living Donor Liver Transplantation in Patients With a History of Ruptured Hepatocellular Carcinoma. Front Surg 2021;8:722098. [PMID: 34733878 DOI: 10.3389/fsurg.2021.722098] [Reference Citation Analysis]
3 Zhang FQ, Li L, Huang PC, Fu YF, Xu QS. Transarterial embolization with hepatectomy for ruptured hepatocellular carcinoma: a meta-analysis. Minim Invasive Ther Allied Technol 2021;:1-8. [PMID: 34634985 DOI: 10.1080/13645706.2021.1986724] [Reference Citation Analysis]
4 Huang Y, Zhang Z, Liao W, Hu K, Wang Z. Combination of Sorafenib, Camrelizumab, Transcatheter Arterial Chemoembolization, and Stereotactic Body Radiation Therapy as a Novel Downstaging Strategy in Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Case Series Study. Front Oncol 2021;11:650394. [PMID: 34408974 DOI: 10.3389/fonc.2021.650394] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ye F, Ma D, Gong XY, Yang YC, Chen YJ. Development and validation of risk score for predicting spontaneous rupture of hepatocellular carcinoma. Ann Surg Treat Res 2020;99:268-74. [PMID: 33163456 DOI: 10.4174/astr.2020.99.5.268] [Reference Citation Analysis]